Figure 4 | British Journal of Cancer

Figure 4

From: An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

Figure 4

Prognostic value of PLK1 and CDK1 expression in MPM tumours. Representative immunohistochemical staining of pleural tissue in patients diagnosed with malignant pleural mesothelioma with PLK1 and CDK1 antibodies. (A) Nuclear staining for PLK1 (left) and nuclear and cytoplasmic staining for CDK1 following IHC testing of MPM tumour tissue. (B) Overall survival from diagnosis according to immunohistochemical expression of PLK1 and CDK1.

Back to article page